Morgan Keegan Reiterates Outperform and PT of $59.50 on Health Care REIT

Morgan Keegan reiterated its outperform rating on Health Care REIT (NYSE: HCN) after the company decided to purchase $80 million worth of real estates.

In a research report published today, Morgan Keegan states, "This will increase Health Care REIT's LTAC holdings to 22 hospitals with an investment balance of $290 million. As our model assumes $100 million of acquisitions per quarter for Health Care REIT this year, there is no change to our estimates."

At the moment, Morgan Keegan has a price target of $59.50 on Health Care's stock. On Monday, Health Care lost 0.16% to close the day at $51.33.